Kevin Deregnier
Family Medicine · Winterset, IANPI 1184708687
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $53,069 of the $67,949 with a category attached, or 78.1%. Novo Nordisk accounts for 83.8% of it on its own, with 44 other manufacturers making up the rest. Reporting peaked in 2019 at $17,825 and has fallen 99.1% since, to $153 in 2025. Among family medicine clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 865 payments — averaging $78.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$57K
- AbbVie$2K
- Pfizer$904
- AstraZeneca$897
- Amgen$816
- Boehringer Ingelheim$744
- plus $5K from 39 others
What the payments were for
- Speaking & faculty fees$53,06978%
- Travel & lodging$2,3783%
- Food & beverage$12,30118%
- Education$2010%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$67,949 in reported general payments places this provider in the 95th percentile of 1,357 family medicine providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 169 | $194,392 |
| EliquisApixaban | 176 | $114,736 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 118 | $88,503 |
| JardianceEmpagliflozin | 80 | $59,546 |
| MounjaroTirzepatide | 26 | $29,002 |
| Tresiba Flextouch U-200Insulin Degludec | 24 | $26,705 |
| XareltoRivaroxaban | 39 | $25,136 |
| CreonLipase/Protease/Amylase | 14 | $22,867 |
| Tresiba Flextouch U-100Insulin Degludec | 56 | $20,704 |
| JanuviaSitagliptin Phosphate | 30 | $18,688 |
| RybelsusSemaglutide | 15 | $14,051 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 20 | $13,502 |
| Victoza 3-PakLiraglutide | 16 | $12,061 |
| Breo ElliptaFluticasone/Vilanterol | 21 | $11,416 |
| TradjentaLinagliptin | 16 | $11,394 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $56,938 | $208,443184 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Arnuity Ellipta | $406 | $116,260170 claims |
| PfizerEliquis | $904 | $114,736176 claims |
| Boehringer IngelheimJardiance, Tradjenta | $744 | $70,94196 claims |
| AbbVieCreon, Linzess | $2,297 | $33,22632 claims |
| Lilly USA, LLCMounjaro | $479 | $29,00226 claims |
| Johnson & JohnsonXarelto | $150 | $25,13639 claims |
| MerckJanuvia | $195 | $18,68830 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $218 | $8,32315 claims |
| AstraZenecaFarxiga | $897 | $6,17723 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $16 | $3,326455 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $18 | $3,16313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,357 family medicine providers in Iowa.
Other family medicine in Winterset
- Kirk PetersonHuxley$576K
- Nicholas GoetschWaterloo$525K
- Stephen HarrisonClinton$249K
- Thomas RossDes Moines$170K
- Yogesh ShahDes Moines$159K
- Leslie George PaulsenMuscatine$136K
- Dylan LoweDes Moines$105K
- Michael AbouassalyWest Burlington$88K
- Laura MoellerAmes$34K
- Matthew SmithWaterloo$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.